A study being presented at the upcoming meeting of the American College of Cardiology found a dose–response relationship between walking and reduced heart failure risk.
Walking for 40 minutes at least 2 to 3 times per week can reduce a woman’s risk of heart failure after menopause, according to a study being presented at the upcoming meeting of the American College of Cardiology (ACC) in Orlando, Florida.
The study looked at how walking—how often, how quickly, and how long during each outing—affected a woman’s heart failure risk over a 10-year period. Researchers led by Somwail Rasla, MD, a cardiology fellow at Saint Vincent Hospital, evaluated data on walking behavior and health outcomes from 89,000 women between the ages of 50 and 79 years who were enrolled in the Women’s Health Initiative. Rasla completed the study during his residency at Brown University.
“We already know that physical activity lowers the risk of heart failure, but there may be a misconception that simply walking isn’t enough,” Rasla said in a statement. “Our analysis shows that walking is not only an accessible form of exercise but almost equal to all different types of exercise that have been studied before in terms of lowering heart failure risk.”
Heart failure, which occurs when the heart is too weak to adequately pump blood through the body, becomes more common with age. The condition, which Rasla called a “global epidemic,” affects 6.5 million US adults and is a leading cause of hospitalization, with total medical costs exceeding $30.7 billion a year.
Patients with heart failure have received increased attention in efforts to reduce readmissions under value-based reimbursement programs in Medicare. Many patients with heart failure have other health problems, including diabetes, obesity, or hypertension.
For women, the risk of heart failure rises after menopause and escalates even more after age 65; according to data from ACC, women aged 75 to 84 years are 3 times more likely to have heart failure than those aged 65 to 74.
Using data from patient questionnaires, the study team categorized walking behavior by frequency, duration, and pace; these 3 variables were combined in a calculation called a Metabolic Equivalent of Task, or MET. The top third of participants for MET per week were 25% less likely to develop heart failure compared with the third with the lowest MET per week.
Researchers excluded those who already had coronary heart disease or cancer or who were unable to walk a block at the start of the study. Not only did they find that walking had a protective effect against heart failure, but there was also a clear dose—response relationship, even after controlling for body mass index, age, and ethnicity.
In response to a question from The American Journal of Managed Care®, Rasla said it appears from the data that even if women start do not start walking immediately after menopause, they will still see benefits once they start.
Walking has been frequently recommended as an accessible, low-cost form of exercise—the previous Surgeon General, Vivek Murthy, MD, recommended walks of at least 22 minutes several times a week to combat obesity.
Rasla will present the study March 12, 2018, at the 67th ACC Scientific Session, which takes place March 10-12 in Orlando, Florida.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
POSITIVE Trial Update on Patients With Breast Cancer Attempting Pregnancy
December 8th 2023At last year’s San Antonio Breast Cancer Symposium, POSITIVE trial primary outcome data were presented on breast cancer–free interval, with women who paused endocrine therapy to attempt pregnancy having a similarly small rate of recurrence vs external controls from the SOFT and TEXT trials: 8.9% vs 9.2%.
Read More
Intermountain Healthcare and Story Health Partner to Optimize Rural Heart Failure Care
February 7th 2023On this episode of Managed Care Cast, we speak with Tom Stanis, CEO and cofounder of Story Health, and Phillip Wood, Intermountain Ventures program director, on how their partnership came about, how it is going so far, and the future of their collaboration.
Listen
New Insights on Breast Cancer Outcomes Among Sexual, Gender Minorities
December 7th 2023Despite there being a great demand for data collection on sexual orientation and gender identity in the cancer space, individuals who identify as a sexual and gender minority remain poorly represented.
Read More
Patients With HFrEF, HFpEF See Different Functional Capacity Benefits With Dapagliflozin
December 7th 2023The DETERMINE-Reduced and DETERMINE-Preserved trials demonstrated varying benefits of dapagliflozin on Kansas City Cardiomyopathy Questionnaire Total Symptom Score and Physical Limitation Scale as well as 6-minute walk distance.
Read More